Methodological standards for comparative effectiveness research: considerations for evidentiary review for medicare drug price negotiation
{{output}}
Introduction: The 2022 Inflation Reduction Act (IRA) is expected to result in lower drug prices for Medicare beneficiaries in the United States (US). The Centers for Medicare & Medicaid Services (CMS) released the most recent dra... ...
